Amgen oncology
「Amgen oncology」熱門搜尋資訊
「Amgen oncology」文章包含有：「AboutOurMissions」、「AmgenOncology」、「Amgen」、「AnticancerModalities」、「BiTE®Molecule」、「OncologyResourcesandResearch」、「OncolyticImmunotherapy」、「ProductPipeline」、「Products」、「Science」
查看更多
About Our Missions
https://www.amgenoncology.com
We are dedicated to delivering new therapies to patients with complex cancers, where there remains significant unmet need to improve outcomes. Our portfolio ...
Amgen Oncology
https://www.amgenoncology.com
At Amgen, we believe that bringing people together can improve cancer outcomes. Hear patient stories and connect with other Amgen destinations to learn more ...
Amgen
https://www.amgen.com
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and ...
Anticancer Modalities
https://www.amgenoncology.com
Learn more about each of the anticancer modalities. See clinical trials and download additional information.
BiTE® Molecule
https://www.amgenoncology.com
BiTE® technology is designed to fight cancer · The BiTE® immuno-oncology platform offers versatility to potentially target any tumor-associated antigen.
Oncology Resources and Research
https://www.amgenoncology.com
A comprehensive interactive resource for Amgen's oncology pipeline, including molecules, targets, malignancies, and clinical trials. No results found.
Oncolytic Immunotherapy
https://www.amgenoncology.com
See how Oncolytic Immunotherapy may slow the progression of cancer by using genetically modified viruses to target tumors.
Product Pipeline
https://www.amgenoncology.com
Explore our investigational agents and clinical trials across a range of solid tumors and hematologic malignancies.
Products
https://www.amgenoncology.com
At Amgen we are committed to changing the course of cancer treatment for more than 40 years. Learn about all of the different Amgen Oncology web propoerties ...
Science
https://www.amgenoncology.com
Learn about the oncology and hematology research, investigational agents, and clinical trials in the pipeline at Amgen.